According to GlaxoSmithKline's latest financial reports the company's current earnings are C$40.25 Billion. In 2023 the company made an earning of C$10.59 Billion, an increase over its 2022 earnings that were of C$9.75 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.